Skip to content

Exor stock

EXO.ASAMS

Exor N.V., Financial ServicesISIN NL0012059018

$81.67▼ $1.17 (−1.4%)Closing price of 12 Nov 2026

47Score 47 out of 100, Weak

Turn on early warning

Price and trend

75 / 100

Price history

−4.4% in one year

The chart shows daily closes over 4 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Above the 200-day line: the price is 6.0% above it.

Trend change

Since September 2026 the 50-day line has been above the 200-day line; the trend has turned up.

Momentum

Overheated: the price has risen very quickly lately (RSI 76).

Distance to the high

The price is 2.5% below its 52-week high. Largest decline in 4 years: 40% (May 2024 to March 2026).

Chart figures for advanced users
SMA 50$78.69
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$77.05
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)76
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$70.49
The lowest closing price of the last twelve months.
Resistance$83.79
The highest closing price of the last twelve months.
Market cap
$26.29B
Div. yield
0.66%
12 months
Loss
Fair value
no data

Snapshot

Computed from the data by fixed rules, no AI

  • Exor N.V. belongs to the Financial (Conglomerates) industry (Netherlands) and, with a market value of $25.92B, is number 5 of 25 companies in its industry on MEQIRI.
  • In fiscal 2025 it reported revenue of $1.16B (down 45.1% year on year) and a loss of $4.22B.
  • MEQIRI Score 47 out of 100 (Weak): rank 879 of 976 in Financial Services, median 68.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Share buybacksShare count down 12% since 2020.Capital allocation 51

Weaknesses

  • Margin fallingOperating margin −438.7%, average of the prior years 9.8% (to 2024).Profitability 10
  • Loss-makingLoss of $4.22B over the last 12 months.Fundamentals 43
  • Turned to a lossEarnings per share from $2.70 in 2021 to −$20.33.Growth 29
47/ 100
MEQIRI Score
Weak

Its standout strengths are stability and technical analysis, while growth and profitability hold the score back.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

Fundamental quality fluctuates.

Profit consistency80% of years
Cash conversion (free cash flow to earnings)not used for financials
ROE (12 months)−13.8%
Positive free cash flownot used for financials
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Valuation

Valuation signal

not measured
Price
$82.84
Fair value
not meaningful
Gap to fair value
no data

Closing price of 11 Nov 2026, used by the daily score.

A fair value is not meaningful here, so the signal follows the valuation grade.

Valuation metrics

0.49
−13.8%
last 12 months, profit over average equity
Fair value (model)
no data

The model puts the fair value at more than four times the share price. That says more about the assumptions than about the company, so a fair value is not meaningful here and the valuation relies on the P/E and the other metrics.

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

2 years

In fiscal 2025, revenue fell 45.1% on the prior year. Revenue has declined since 2024 (-45% per year), so it is worth watching closely. From 2024 revenue is reported differently (for example gross instead of net), so earlier years are not comparable and not shown.

Margins

2 years
  • Operating margin
  • Net margin

In fiscal 2025: operating −439%, net −364%. Banks and insurers have no gross margin, and their net margin is not comparable with other industries. The score leaves both out. Last 12 months: net 100%. From 2024 revenue is reported differently (for example gross instead of net), so earlier years are not comparable and not shown.

Debt & balance sheet

latest quarter
0.12
Equity
$33.81B
27.68
Cash & equivalents
$1.07B

For banks and insurers, deposits and liabilities are the business. Debt to equity and the current ratio say little here, and the score does not rate them.

Earnings

Next earnings
31 Mar 2027in 139 days
Last reported
22 Sep 2026EPS reported −$6.18

Analyst estimates

Fiscal 20262 analysts
Earnings per share
$3.10+18.7%
Revenue
$1.11M−99.9%
Fiscal 20272 analysts
Earnings per share
$1.67+26.2%
Revenue
$1.11M−99.8%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

What happened at Exor

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

976 rated companies in Financial Services

Rank 879 of 976
879/ 976
This company
47
Sector median
68

Categories against the sector medianMedian of 976 companies

Profitability10 (median 57)47 below the median
Growth29 (median 67)38 below the median
Fundamentals43 (median 80)37 below the median
Stability85 (median 78)7 above the median
Capital allocation51 (median 56)5 below the median
Technical analysis75 (median 70)5 above the median
Momentum66 (median 70)4 below the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Financial (Conglomerates)

The next larger and next smaller companies by market value

All 25 Financial (Conglomerates) stocks

ETFs that hold Exor

Held by 97 ETFs on Xetra. Shown per index: the ETF with the largest weight.

Show 5 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Currency
Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = €0.8987)
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Weak, published since 7 Nov 2026 (in the score history since 24 Oct 2026)
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy